Recruiting

Mindfulness Messages

Sponsor:

University of New Mexico

Code:

NCT07350148

Conditions

Opioid Use Disorder (OUD)

Chronic Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mindfulness text messages

Study Details

Brief summary:

The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are:

1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder?
2. To what extent do people engage with the daily mindfulness messages?
3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms?

Participants will:

1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months)
2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month)
3. Answer daily questions twice a day during the 4 weeks of mindfulness messages
4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages

Conditions

Opioid Use Disorder (OUD)

Chronic Pain

Study ID

NCT07350148

Start date

Oct 13, 2025

Status verified date

Jan, 2026

Completion date

Mar, 2029

Anticipated

Primary completion date

Mar, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 18 years of age or older
  • Have a cellphone that can receive text messages
  • Have internet access to complete study surveys
  • Willing to comply with all study procedures and be available for the duration of the study
  • Within 6 months of starting or resuming to take daily methadone or buprenorphine (or suboxone/subutex)
  • Able to understand study requirements and provide informed consent

Exclusion Criteria:

  • None

Study Design

Enrollment

60 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Mindfulness text messages

Interventions

Mindfulness text messages

Over 250 text messages based on concepts from Mindfulness-Based Relapse Prevention (MBRP) were developed and are sent to participants each day for 4 weeks. The messages are intended to increase awareness of triggers and "automatic" reactions to triggering experiences, and to consider alternative responses to these experiences.

Primary outcome measure

  • Mindfulness text intervention engagement [ Time Frame: Measured daily for four weeks ]
  • Intervention acceptability [ Time Frame: From baseline to 24-week (i.e., 6-month) follow-up ]
  • Intervention feasibility [ Time Frame: From baseline to 24-week (i.e., 6-month) follow-up ]
  • Medication adherence [ Time Frame: From baseline to 24-week (6-month) follow-up ]

Central Contacts and Locations

Central contacts

Frank Schwebel, PhD

505-456-3014fschwebel@unm.edu

Locations

University of New Mexico

Recruiting

Albuquerque, New Mexico, United States, 87131

Contacts

Frank Schwebel, PhD

505-456-3014fschwebel@unm.edu

Principal Investigator:

Frank Schwebel, PhD

More Information

Sponsor

University of New Mexico

Last update posted

Jan 20, 2026

Last verified

Jan, 2026

Keywords

  • text message
  • medications for opioid use disorder
  • mHealth
  • mindfulness
  • medication adherence

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of New Mexico on 2026-01-20.